Advertisement

Digestive Diseases and Sciences

, Volume 39, Issue 6, pp 1193–1196 | Cite as

Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis

  • M. V. Madden
  • A. S. McIntyre
  • R. J. Nicholls
Original Articles

Abstract

Metronidazole has been used to treat pouchitis, but there are no controlled data that show it is effective. Chronic unremitting pouchitis is a form of the disorder particularly difficult to manage. Diarrhea is the main symptom of pouchitis, which results from acute inflammation of the mucosa of an ileal reservoir. To test the hypothesis that metronidazole (400 mg thrice daily for seven days) is no better than placebo at reducing stool frequency in chronic unremitting pouchitis, a double-blind placebo-controlled crossover study has been performed. Thirteen patients who had undergone restorative proctocolectomy for ulcerative colitis were studied. The diagnosis of pouchitis was based on clinical, endoscopic, and histological criteria. At entry all patients had symptomatic pouchitis and were passing more than six stools/24 hr or had consistently bloody stools with at least four of six endoscopic criteria of mucosal inflammation. The median frequency of defecation decreased by 3 bowel action/24 hr (conservative 95% confidence intervals 0–4/24 hr) on metronidazole but increased by a median of 1/24 hr on placebo. The difference between the median number of bowel motions, when treatment with metronidazole was compared to placebo, was 4 motions/24 hr (P<0.05) in favor of metronidazole. There was no significant change in the endoscopic or histological grade of inflammation, in the serum C-reactive protein level, or symptomatic scores. In a parallel study, metronidazole did not alter stool frequency in asymptomatic patients without pouchitis who had endoscopically normal reservoirs (six polyposis, six colitis). Metronidazole significantly reduces the frequency of defecation when compared with placebo in chronic pouchitis. The reduction in stool frequency is, however, of limited symptomatic benefit to the patient.

Key words

ulcerative colitis pouchitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Madden MV, Farthing MJG, Nicholls RJ: Inflammation in ileal reservoirs—“pouchitis.” Gut 31:247–249, 1990Google Scholar
  2. 2.
    Pemberton JH, Kelly KA, Beart RW, Dozois RR, Wolff BG, Ilstrup DM: Ileal pouch-anal anastomosis for chronic ulcerative colitis. Long-term results. Ann Surg 206:504–513, 1987Google Scholar
  3. 3.
    Oresland T, Fasth S, Nordgren S, Hulten L: The clinical and functional outcome after restorative proctocolectomy. Int J Colorect Dis 4:50–56, 1989Google Scholar
  4. 4.
    Kmiot WA, Keighley MRB: Pouchitis following colectomy and ileal reservoir construction for familial adenomatous polyposis. Br J Surg 77:1283, 1990Google Scholar
  5. 5.
    Becker JM, Raymond JL: Ileal pouch-anal anastomosis. A single surgeon's experience with 100 consecutive cases. Ann Surg 204:375–383, 1986Google Scholar
  6. 6.
    Dozois RR: Symposium. Restorative proctocolectomy with ileal reservoir. Int J Colorect Dis 1:14–15, 1986Google Scholar
  7. 7.
    Gustavsson S, Weiland LH, Kelly KA: Relationship of backwash ileitis to ileal pouchitis after ileal pouch-anal anastomosis. Dis Colon Rectum 30:25, 1987Google Scholar
  8. 8.
    Lohmuller JL, Pemberton JH, Dozois RR, Ilstrup D: The relationship between pouchitis after ileal pouch-anal anastomosis and extra-intestinal manifestations of chronic ulcerative colitis. Ann Surg 211:622–629, 1990Google Scholar
  9. 9.
    Moskowitz RL, Shepherd NA, Nicholls RJ: An assessment of inflammation in the reservoir after restorative protocolectomy with ileoanal ileal reservoir. Int J Colorect Dis 1:167–174, 1986Google Scholar
  10. 10.
    Shepherd NA, Jass JR, Duval I, Moskowitz RL, Nicholls RJ, Morson BC: Restorative proctocolectomy with ileal reservoir: Pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 40:601–607, 1987Google Scholar
  11. 11.
    American Hospital Formularly Service: AHFS Drug Information 1991:475–476, 1991Google Scholar
  12. 12.
    Nicholls RJ, Belliveau P, Neill M, Wilks M, Tabaqchali S: Restorative protocolectomy with ileal reservoir: A pathophysiological assessment. Gut 22:462–468, 1991Google Scholar
  13. 13.
    Kelly DG, Philips SF, Kelly KA, Weinstein WM, Gilchrist MJ: Dysfunction of the continent ileostomy: clinical features and bacteriology. Gut 24:193–201, 1983Google Scholar
  14. 14.
    O'Connell PR, Rankin DH, Weiland LH, Kelly KA: Enteric bacteriology, absorption, morphology and emptying after ileal pouch-anal anastomosis. Br J Surg 73:909–914, 1986Google Scholar
  15. 15.
    Luukonen P, Valtonen V, Sivonen A, Sipponen P, Jarvinen H: Fecal bacteriology and reservoir ileitis in patients operated on for ulcerative colitis. Dis Colon Rectum 31:864–867, 1988Google Scholar
  16. 16.
    Hill MJ, Fernandes F: Bacteriology (II). Workshop. Pouchitis. Int J Colorect Dis 4:204–209 and 217–219, 1989Google Scholar
  17. 17.
    Hill MJ, Owen RW: Faecal bile acids in pouch and pouchitis patients. Workshop. Pouchitis. Int J Colorect Dis 4:221–222, 1989Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • M. V. Madden
    • 1
  • A. S. McIntyre
    • 1
  • R. J. Nicholls
    • 1
  1. 1.St. Mark's HospitalLondonUK

Personalised recommendations